| Authors: |
Swaminathan M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Ferrajoli A; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Thompson PA; Department of Clinical Hematology, Peter MacCallum Cancer Center, Melbourne, Australia., Burger J; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Borthakur G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Takahashi K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Estrov Z; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Bharathi V; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Bataller A; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Kadia TM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Pemmaraju N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Daver N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Jabbour E; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Bose P; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Kanagal-Shamanna R; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Patel KP; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Wang SA; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Garg N; Department of Radiology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Hwang H; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas., Wang X; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas., Qiao W; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas., Xu X; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas., Cruz N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Ayala A; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Pierce S; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Plunkett W; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas., Sampath D; Department of Hematopoietic Biology and Malignancy, The University of Texas MD Anderson Cancer Center, Houston, Texas., Kantarjian HM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Keating MJ; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Gandhi V; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas., Wierda WG; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Jain N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas. |
